Pharmacological Basis of β-Lactamase Inhibitor Therapeutics: Tazobactam in Combination with Ceftolozane

We recently investigated the pharmacokinetics-pharmacodynamics (PK-PD) of tazobactam in combination with ceftolozane against an isogenic CTX-M-15-producing Escherichia coli triplet set, genetically engineered to transcribe different levels of bla(CTX-M-15). The percentage of the dosing interval that...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: VanScoy, Brian, Mendes, Rodrigo E., McCauley, Jennifer, Bhavnani, Sujata M., Bulik, Catharine C., Okusanya, Olanrewaju O., Forrest, Alan, Jones, Ronald N., Friedrich, Lawrence V., Steenbergen, Judith N., Ambrose, Paul G.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: American Society for Microbiology 2013
Konular:
Pharmacology
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3837916/
https://ncbi.nlm.nih.gov/pubmed/24041895
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.00656-13
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller